MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Alimentary Pharmacology & Therapeutics
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

774 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
774 works in the cohort · of 4,299,418page 1 of 16

Labels cover 2 of 774 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 774 of 774 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

aboutno affunlabeled
The economic impact of irritable bowel syndrome
John M. Inadomi, M. Brian Fennerty, David J. Bjorkman
2003· review· en· Alimentary Pharmacology & Therapeutics· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
193
citations
affunlabeled
Long‐term safety of vedolizumab for inflammatory bowel disease
Edward V. Loftus, Brian G. Feagan, Remo Panaccione, Jean‐Frédéric Colombel, William J. Sandborn, Bruce E. Sands +8 more
2020· article· en· Alimentary Pharmacology & Therapeutics· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
191
citations
affunlabeled
Systematic review: safety of mesalazine in ulcerative colitis
Priya Sehgal, Jean‐Frédéric Colombel, Aiya Aboubakr, Neeraj Narula
2018· review· en· Alimentary Pharmacology & Therapeutics· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
179
citations
next →

How this was built: Screen · Findings · About